Source: FinanzNachrichten

Orteq: Orteq Sports Medicine Announces Publication of 5-year Multi-Center Clinical Data for the Actifit Meniscal Scaffold in the American Journal of Sports Medicine (AJSM), Receives FDA Breakthrough Device Designation

LONDON, May 26, 2020 /PRNewswire/ -- Orteq Sports Medicine Ltd. (www.orteq.com), a developer of joint preservation solutions for orthopedic patients, announces 5-year, multi center, peer-reviewed ...

Read full article »
Orteq's Competitors | Orteq's News | Orteq's Financials
Stay up-to-date with the latest news on Orteq
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
David W. Anderson's photo - CEO of Orteq

CEO

David W. Anderson

CEO Approval Rating

60/100

Read more
Stay up-to-date with the latest news on Orteq